The European Journal of Cardiovascular Nursing (EJCN) is a peer-reviewed international journal dedicated to the advancement of knowledge in the field of cardiovascular care and the promotion of evidence-based clinical practice.
The journal publishes original articles, short report reviews and editorials in order to improve the quality of care for patients with cardiovascular disease. The peer-reviewed journal of the European Society of Cardiology’s Association of Cardiovascular Nursing and Allied Professions (CCNAP) covers the broad field of cardiovascular nursing and care including chronic and acute care, cardiac rehabilitation, primary and secondary prevention, heart failure, acute coronary syndromes, interventional cardiology, cardiac care, and vascular care.
This journal offers optional Open Access through the SAGE Choice programme. Visit the SAGE Open Access website for more information.
This journal is a member of the Committee on Publication Ethics (COPE)
European Society of Cardiology Journal Family
The European Journal of Cardiovascular Nursing is a peer-reviewed international journal dedicated to the advancement of knowledge in the field of cardiovascular nursing and the promotion evidence-based clinical practice.
The journal publishes original articles, short reports, reviews and editorials in order to improve the quality of nursing care for patients with cardiovascular disease. Original contributions on the broad field of cardiovascular nursing are welcome, including chronic and acute care, paediatric cardiology, grown up congenital heart disease, cardiac rehabilitation, primary and secondary prevention, heart failure, acute coronary syndromes, interventional cardiology, cardiac care, preventive cardiology, and vascular nursing.
Scientific contributions can be related to all aspects of care: education, research, patient care or organisational aspects. Additional contributions on epidemiology, physiology, pharmacology or psychology related to cardiovascular nursing are welcome.
|Prof. Dr. Tiny Jaarsma||Linköping University, Sweden|
|Prof. Dr. Anna Stromberg||Linköping University Hospital, Sweden|
|Prof. David Thompson||Queen's University Belfast, UK|
|Prof. Dr. Bengt Fridlund||Jönköping, Sweden|
|Prof. Dr. Simon Stewart||Mary MacKillop Institute for Health Research, Melbourne, Australia|
|Prof. Dr. Philip Moons||Katholieke Universiteit Leuven, Belgium|
|Prof. Inger Ekman||Göteborg University, Sweden|
|Dr. Mattie Lenzen||Rotterdam, Netherlands|
|Prof. Mariann R. Piano||Vanderbilt University School of Nursing, USA|
|Dr. Kristofer Årestedt||Linköping University, Sweden|
|Prof. Dr. Christopher Lee||Connell School of Nursing, USA|
|Dr. Selina Kikkenborg Berg||Copenhagen, Denmark|
|Dr. Anders Broström||Linköping University Hospital, Sweden|
|Lorraine S. Evangelista||University of California Irvine, USA|
|Dr. Catriona Jennings||NHLI Imperial College London, UK|
|Dr. Naoko P. Kato||The University of Tokyo Graduate School of Medicine, Japan|
|Dr Barbro Kjellström||Karolinska University Hospital, Sweden|
|Leonie Klompstra||Linköping University, Sweden|
|Prof. Dr. Jan Mårtensson||Jönköping University, Sweden|
|Prof. Dr. Philip Moons||Katholieke Universiteit Leuven, Belgium|
|Professor Tone M. Norekval||Haukeland University Hospital, Norway|
|Nora Östrup||Linköping University, Sweden|
|Prof. Dr. Felicity Astin||University of Huddersfield, UK|
|Prof. Jelena Celutkiene||Vilnius University Santariškiu, Lithuania|
|Dr. Asa Cider||University of Gothenburg, Sweden|
|Prof. Dr. Patricia Davidson||John Hopkins University, United States, USA|
|Prof. Dr. Sabina de Geest||University of Basel, Switzerland|
|Prof. Dr. Christi Deaton||University of Cambridge, UK|
|Professor Donna Fitzsimons||Queen’s University Belfast, UK|
|Dr. Tina Birgitte Hansen||Zealand University Hospital and University of Southern Denmark, Denmark|
|Dr Jeroen Hendriks||The University of Adelaide, Australia|
|Dr. Boyoung Hwang||Seoul National University, Korea|
|Dr. Peter Johansson||Linköping University Hospital, Sweden|
|Dr Rani Khatib||Leeds Teaching Hospitals NHS Trust, UK|
|Prof. Dr. Kathryn King-Shier||University of Calgary, Canada|
|Dr. Stefan Köberich||Heart Center, University of Freiburg, Germany|
|Dr. Mitja Lainšcak||General Hospital Celje, Slovenia|
|Ekaterini Lambrinou||Cyprus University of Technology, Cyprus|
|Prof. Dr. Christopher Lee||Connell School of Nursing, USA|
|Prof. Dr. Terrie A. Lennie||University of Kentucky, USA|
|Prof. Dr. Debra K. Moser||University of Kentucky, USA|
|Prof. Lis Neubeck||Edinburgh Napier University, UK|
|Professor Samar Noureddine||American University of Beirut, Lebanon|
|Prof. Dr. Barbara Riegal||University of Pennsylvania, USA|
|Dr. Jilian Riley||Royal Brompton & Harefield NHS Foundation Trust, UK|
|Dr. Chantal F Ski||Queen’s University Belfast, UK|
|Dr. Karen Smith||The University of Dundee, UK|
|Prof. Dr. Patricia H. Strachan||Mc Master University, Canada|
|Dr Martje H.L. van der Wal||University Medical Center Groningen, the Netherlands|
|Dr. Ercole Vellone||University of Rome "Tor Vergata", Italy|
|Dr Wenru Wang||National University of Singapore, Singapore|
This Journal is a member of the Committee on Publication Ethics
This Journal recommends that authors follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals formulated by the International Committee of Medical Journal Editors (ICMJE)
Please read the guidelines below then visit the Journal’s submission site http://www.editorialmanager.com/cnu to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned.
Only manuscripts of sufficient quality that meet the aims and scope of European Journal of Cardiovascular Nursing will be reviewed.
There are no fees payable to submit or publish in this journal.
As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.
- What do we publish?
1.1 Aims & Scope
1.2 Article types
1.3 Writing your paper
- Editorial policies
2.1 Peer review policy
2.5 Declaration of conflicting interests
2.6 Research ethics and patient consent
2.7 Clinical trials
2.8 Reporting guidelines
- Publishing policies
3.1 Publication ethics
3.2 Contributor's publishing agreement
3.3 Open access and author archiving
- Preparing your manuscript
4.2 Artwork, figures and other graphics
4.3 Supplementary material
4.4 Reference style
4.5 English language editing services
4.6 Publication of Twitter handles
- Submitting your manuscript
5.2 Information required for completing your submission
- On acceptance and publication
6.1 SAGE Production
6.2 Online First publication
6.3 Access to your published article
6.4 Promoting your article
- Further information
Before submitting your manuscript to European Journal of Cardiovascular Nursing, please ensure you have read the Aims & Scope.
The European Journal of Cardiovascular Nursing accepts original research, short reports and review articles.
Original research: The text should be arranged as follows: (1) Title Page, (2) Abstract, (3) Keywords, (4) Introduction, (5) Methods, (6) Results, (7) Discussion, (8) Implications for Practice, (9) Acknowledgments, (10) References, (11) Figures and Tables.
The maximum length for original research and review articles is 3,500 words. The maximum length for a short report is 2,000 words.
(1) Title page: Please include the following:
Title: Concise and informative. Avoid abbreviations and formulae where possible.
Author names and affiliations: Where the family name may be ambiguous (e.g., a double name), please indicate this clearly. Present the authors' affiliation addresses (where the actual work was done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after the author's name and in front of the appropriate address. Provide the full postal address of each affiliation, including the country name and, if available, the e-mail address of each author.
Corresponding author: Clearly indicate who will handle correspondence at all stages of refereeing and publication, also post-publication. Ensure that telephone and fax numbers (with country and area code) are provided in addition to the e-mail address and the complete postal address. If you would like to publish your twitter handle as part of the corresponding author information please include your twitter handle on the title page and also when prompted in the Editorial Manager Submission form. To find out more please see 4.6 Publication of Twitter handles
Present/permanent address: If an author has moved since the work described in the article was done, or was visiting at the time, a 'Present address' (or 'Permanent address') may be indicated as a footnote to that author's name. The address at which the author actually did the work must be retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.
Please submit the title page separately to the main text of the article to facilitate anonymous peer review (see section 2.1 below).
(2) Abstract: An abstract (maximum 250 words) should be typed double spaced on a separate page. It should be structured and include background, aims, methods and results and conclusion.
(3) Keywords: No more than six keywords are required.
The title, keywords and abstract are key to ensuring readers find your article online through online search engines such as Google. Please refer to the information and guidance on how best to title your article, write your abstract and select your keywords by visiting the SAGE Journal Author Gateway for guidelines on How to Help Readers Find Your Article Online
(4) Introduction: This section should position the study with regard to objective, rationale and preceding work of other authors.
(5) Methods: This section should contain a statement that "The investigation conforms with the principles outlined in the Declaration of Helsinki" (Br Med J 1964;ii:177). The methods section should be sufficiently detailed for repetition of the study by other scientists. If pertinent, the section may be divided into headed subsections.
(6) Results: If pertinent, the section may be divided into headed subsections. For presentation of data, figures are preferred to tables. Data should not be presented in both figures and tables. Also, extensive numerical data should appear in legends to the figures rather than in the main body of text. SI units should be used.
(7) Discussion: This section should deal with topics that are beyond the scope of the study, compare and interpret the data with regard to previous work by (other) authors.
(8) Implications for Practice: Please provide three to five key bullet points that summarise the implications of their paper for practice. The aim of these is to encourage others to use the findings in their daily practice of patient care, education or research based on the stated points. Please ensure each bullet is no longer than 50 characters. These bullet points will be published as part of the article.
(9) Acknowledgments: please refer to guidance in section 2 below.
(10) References: please refer to guidance in section 4 below on how to format your references. As a general guide we recommend no more than 30 references for original articles and 70 for review articles; if you have more than this please contact the Editorial Office to discuss.
(11) Figures and Tables: Figures should be designed in a way compatible with reproduction of one column width. Figures over two columns should be kept to a minimum. Tables should not contain data not mentioned in the text. Laser prints of good quality are sufficient for graphs and tables. Glossy prints are needed for micrographs, etc. Figure legends should start on a new page of the manuscript, but one page may contain legends to more than one figure.
Short Reports: These reports should not exceed 2,000 words and should consist of:
The (maximum number of) 2,000 words may be allocated as you consider appropriate. The editorial team reserves the right to decide which tables/figures submitted are necessary.
Case Reports: If a high quality case report is submitted but not appropriate for European Journal of Cardiovascular Nursing it may be offered for transfer to European Heart Journal - Case Reports (EHJCR). EHJCR is the international, online-only, fully open access journal of the ESC. The Journal publishes high quality, educationally valuable case reports, images, and quality improvement projects in all aspects of cardiology and cardiovascular medicine. More information can be found at https://academic.oup.com/ehjcr.
The SAGE Author Gateway has some general advice and on how to get published, plus links to further resources.
1.3.1 Make your article discoverable
When writing up your paper, think about how you can make it discoverable. The title, keywords and abstract are key to ensuring readers find your article through search engines such as Google. For information and guidance on how best to title your article, write your abstract and select your keywords, have a look at this page on the Gateway: How to Help Readers Find Your Article Online.
EJCN operates a blinded peer review process in which the reviewer's name is withheld from the author and the author's name from the reviewer. The reviewer may at their own discretion opt to reveal their name to the author in their review but our standard practice is for both identities to remain concealed.
Manuscripts are normally evaluated by three members from an international panel of reviewers. An editorial decision is normally taken within 28 days of receipt of a manuscript.
The Editor or members of the Editorial Board may occasionally submit their own manuscripts for possible publication in the journal. In these cases, the peer review process will be managed by alternative members of the Board and the submitting Editor/Board member will have no involvement in the decision-making process.
Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.
The list of authors should include all those who can legitimately claim authorship. This is all those who:
- Made a substantial contribution to the concept or design of the work; or acquisition, analysis or interpretation of data,
- Drafted the article or revised it critically for important intellectual content,
- Approved the version to be published,
- Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.
Authors should meet the conditions of all of the points above. When a large, multicentre group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.
Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship.
All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.
2.3.1 Writing assistance
Individuals who provided writing assistance, e.g. from a specialist communications company, do not qualify as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance – including the individual’s name, company and level of input – and identify the entity that paid for this assistance.
It is not necessary to disclose use of language polishing services.
Any acknowledgements should appear first at the end of your article prior to your Declaration of Conflicting Interests (if applicable), any notes and your References.
European Journal of Cardiovascular Nursing requires all authors to acknowledge their funding in a consistent fashion under a separate heading. Please visit the Funding Acknowledgements page on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding, or state that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
It is the policy of European Journal of Cardiovascular Nursing to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.
Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgements and prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’. For guidance on conflict of interest statements, please see the ICMJE recommendations here.
Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki.
Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.
For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal.
Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative.
Please also refer to the ICMJE Recommendations for the Protection of Research Participants.
European Journal of Cardiovascular Nursing conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.
The relevant EQUATOR Network reporting guidelines should be followed depending on the type of study. For example, all randomized controlled trials submitted for publication should include a completed CONSORT flow chart as a cited figure and the completed CONSORT checklist should be uploaded with your submission as a supplementary file. Systematic reviews and meta-analyses should include the completed PRISMA flow chart as a cited figure and the completed PRISMA checklist should be uploaded with your submission as a supplementary file. The EQUATOR wizard can help you identify the appropriate guideline.
Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives.
SAGE is committed to upholding the integrity of the academic record. We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors and view the Publication Ethics page on the SAGE Author Gateway.
European Journal of Cardiovascular Nursing and SAGE take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of published articles. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked with duplication-checking software. Where an article, for example, is found to have plagiarised other work or included third-party copyright material without permission or with insufficient acknowledgement, or where the authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article; taking up the matter with the head of department or dean of the author's institution and/or relevant academic bodies or societies; or taking appropriate legal action.
3.1.2 Prior publication
If material has been previously published it is not generally acceptable for publication in a SAGE journal. However, there are certain circumstances where previously published material can be considered for publication. Please refer to the guidance on the SAGE Author Gateway or if in doubt, contact the Editor at the address given below.
Before publication, SAGE requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. SAGE’s Journal Contributor’s Publishing Agreement is an exclusive licence agreement which means that the author retains copyright in the work but grants SAGE the sole and exclusive right and licence to publish for the full legal term of copyright. Exceptions may exist where an assignment of copyright is required or preferred by a proprietor other than SAGE. In this case copyright in the work will be assigned from the author to the society. For more information please visit the SAGE Author Gateway.
European Journal of Cardiovascular Nursing offers optional open access publishing via the SAGE Choice programme. For more information please visit the SAGE Choice website. For information on funding body compliance, and depositing your article in repositories, please visit SAGE Publishing Policies on our Journal Author Gateway.
The preferred format for your manuscript is Word. LaTeX files are also accepted. Word and (La)Tex templates are available on the Manuscript Submission Guidelines page of our Author Gateway.
For guidance on the preparation of illustrations, pictures and graphs in electronic format, please visit SAGE’s Manuscript Submission Guidelines.
Figures supplied in colour will appear in colour online and in the print issue. There is no charge for reproducing figures in colour in the printed version.
- Make sure you use uniform lettering and sizing of your original artwork,
- Save text in illustrations as 'graphics' or enclose the font,
- Only use the following fonts in your illustrations: Arial, Courier, Times, Symbol,
- Number the illustrations according to their sequence in the text,
- Use a logical naming convention for your artwork files,
- Provide captions to illustrations separately,
- Produce images near to the desired size of the printed version,
- Submit each figure as a separate file.
Please do not:
- Supply files that are optimised for screen use (e.g., GIF, BMP, PICT, WPG); the resolution is too low,
- Supply files that are too low in resolution,
- Submit graphics that are disproportionately large for the content.
This journal is able to host additional materials online (e.g. datasets, podcasts, videos, images etc) alongside the full-text of the article. For more information please refer to our guidelines on submitting supplementary files.
European Journal of Cardiovascular Nursing adheres to the SAGE Vancouver reference style. View the SAGE Vancouver guidelines to ensure your manuscript conforms to this reference style.
Authors seeking assistance with English language editing, translation, or figure and manuscript formatting to fit the journal’s specifications should consider using SAGE Language Services. Visit SAGE Language Services on our Journal Author Gateway for further information.
As a way of encouraging ongoing discussion within the field, EJCN authors are offered the option of providing their personal and/or institutional Twitter handle to be published alongside their name and email address within their article. This way EJCN readers who have questions or thoughts regarding your paper can tweet you or your institution directly. Providing a Twitter handle for publication is entirely optional; if you are not comfortable with EJCN promoting your article along with your personal and/or institutional personal Twitter handles then please do not supply them.
By providing a Twitter handle you agree to allow EJCN, the ESC, ACNAP and SAGE Publishing use it in any posts related to your journal article. You may also be contacted by other Twitter users. EJCN, the ESC, ACNAP and SAGE Publishing will have no control over you or your tweets at any time. If you would like guidance on how to promote your article yourself on Twitter or other Social Media channels please visit https://uk.sagepub.com/en-gb/eur/promote-your-article
To include your Twitter handle within your article, please provide this within the Editorial Manager Submission form when prompted and also on the Title Page for the manuscript. Your contact information will appear as below within the published article:
Professor Joe Bloggs, Department of Cardiovascular Nursing, Nursing University, Cardiovascular Road, EJ4 4CN
Email: JoeBloggs@email.com Twitter: @profjoebloggs @UniversityofEJCN
European Journal of Cardiovascular Nursing is hosted on Editorial Manager, a web based online submission and peer review system. Visit http://www.editorialmanager.com/cnu to login and submit your article online.
All papers must be submitted via the online system. If you would like to discuss your paper prior to submission, please contact the editorial office: firstname.lastname@example.org
A covering letter should include a declaration that "the manuscript, or part of it, has neither been published (except in the form of abstract or thesis) nor is currently under consideration for publication by any other journal". Secondly, the submitting author should declare that the co-author(s) has (have) read the manuscript and approved its submission to the European Journal of Cardiovascular Nursing.
As part of our commitment to ensuring an ethical, transparent and fair peer review process SAGE is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID provides a persistent digital identifier that distinguishes researchers from every other researcher and, through integration in key research workflows such as manuscript and grant submission, supports automated linkages between researchers and their professional activities ensuring that their work is recognised.
We encourage all authors to add their ORCIDs to their SAGE Track accounts and include their ORCIDs as part of the submission process. If you don’t already have one you can create one here.
You will be asked to provide contact details and academic affiliations for all co-authors via the submission system and identify who is to be the corresponding author. These details must match what appears on your manuscript. At this stage please ensure you have included all the required statements and declarations and uploaded any additional supplementary files (including reporting guidelines where relevant).
Please also ensure that you have obtained any necessary permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please see the Copyright and Permissions page on the SAGE Author Gateway.
Your SAGE Production Editor will keep you informed as to your article’s progress throughout the production process. Proofs will be sent by PDF to the corresponding author and should be returned promptly. Authors are reminded to check their proofs carefully to confirm that all author information, including names, affiliations, sequence and contact details are correct, and that Funding and Conflict of Interest statements, if any, are accurate. Please note that if there are any changes to the author list at this stage all authors will be required to complete and sign a form authorising the change.
Online First allows final articles (completed and approved articles awaiting assignment to a future issue) to be published online prior to their inclusion in a journal issue, which significantly reduces the lead time between submission and publication. Visit the SAGE Journals help page for more details, including how to cite Online First articles.
SAGE provides authors with online access to their final article.
Publication is not the end of the process! You can help disseminate your paper and ensure it is as widely read and cited as possible. The SAGE Author Gateway has numerous resources to help you promote your work. Visit the Promote Your Article page on the Gateway for tips and advice.
Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the European Journal of Cardiovascular Nursing editorial office as follows: